We describe the case of septic arthritis in a 58-year-old woman with a history of rheumatoid arthritis and ulcerative colitis on immunosuppressive therapy with rituximab. Treatment with anti-CD20 antibodies (eg, rituximab) leads to an immediate depletion of B cells and hence risk of reductions in immunoglobulins and increased risk of infections. This effect may last long after drug cessation. is commensal to the genitourinary tract in sexually active adults. Extragenital infections including septic arthritis are rare, but hypogammaglobulinaemia is a predisposing factor. As requires extended culture, special media or PCR analysis, it is not tested routinely, which in many cases delays diagnosis and correct treatment. In our case, a diagnosis of septic arthritis was made after 9 weeks by PCR analysis and culture of joint fluid. The patient responded well to an 8-week treatment course of moxifloxacin and doxycycline.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817823 | PMC |
http://dx.doi.org/10.1136/bcr-2020-237798 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!